Antiplatelet and Lipid Therapy for ACS With Drug-Eluting Stents
Part of Heart & circulation clinical trials.
This trial tests two different antiplatelet and cholesterol-lowering drug combinations in people who have had a heart attack or unstable angina and received a drug-eluting stent. The goal is to find the best way to prevent future heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 85 years old.
- You have had a heart attack or unstable angina and were treated with a drug-eluting stent.
- You are not currently taking blood thinners like warfarin or apixaban.
- You do not have a condition that makes muscle problems more likely, such as a muscle disorder, low thyroid, severe liver disease, or heavy alcohol use.
- You are not pregnant or planning to become pregnant.
- You have no history of serious side effects or allergy to statins, and you are not taking medications that strongly interact with statins.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tailoring anti-platelet (blood clot prevention) treatment can better protect people at higher risk of heart or blood-vessel problems after a drug-eluting stent. It may help prevent future clots and complications, especially in patients with certain high-risk health conditions or complex stent/scar tissue features.
This study looks at whether choosing blood thinners based on each person's needs works better than a standard approach after getting a heart stent. It aims to reduce risks like blood clots or bleeding.
This trial studies a drug-coated balloon (plus standard heart medicines) to treat a specific type of blockage in the heart arteries in people who need an intervention. It may help keep the artery open and prevent the narrowing from coming back, depending on how well you match the detailed heart and medication requirements.
This trial compares two types of drug-coated stents (one with sirolimus, one with everolimus) in people who have had a heart attack or unstable angina and need a stent. It aims to see which stent works better for new blockages in the heart arteries.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This study looks at how to treat blocked heart arteries that have narrowed again after a prior drug-eluting stent. It compares using another drug-eluting stent versus a drug-coated balloon, chosen based on an imaging scan inside the artery (OCT), to reduce repeat narrowing.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.